Monaco Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Monaco Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$203K	–	102
2025 Q2	$203K	Buy	+20,000	New	+$134K	0.04%	91
2025 Q1	–	Sell	-135,561	Closed	-$1.09M	–	94
2024 Q4	$1.09M	Sell	135,561 -15,000	-10%	-$138K	0.16%	57
2024 Q3	$1.54M	Sell	150,561 -151,089	-50%	-$1.49M	0.22%	49
2024 Q2	$2.13M	Buy	301,650 +171,650	+132%	+$1.54M	0.34%	32
2024 Q1	$1.79M	Sell	130,000 -150,000	-54%	-$1.78M	0.54%	32
2023 Q4	$2.58M	Sell	280,000 -104,793	-27%	-$758K	0.76%	37
2023 Q3	$2.33M	Buy	384,793 +6,571	+2%	+$53.8K	0.69%	34
2023 Q2	$2.94M	Sell	378,222 -173,527	-31%	-$986K	0.82%	30
2023 Q1	$3.14M	Sell	551,749 -5,681	-1%	-$29.7K	0.96%	25
2022 Q4	$3.28M	Buy	557,430 +216,248	+63%	+$730K	0.99%	30
2022 Q3	$1.09M	Sell	341,182 -23,559	-6%	-$94.3K	0.42%	41
2022 Q2	$1.63M	Buy	+364,741	New	+$1.46M	0.71%	31

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Monaco Asset Management's ORIC Position: Q3 2025 in Review

Monaco Asset Management sold out of Oric Pharmaceuticals (ORIC) in Q3 2025, closing a stake of 20,000 shares — an estimated $203K sold.

Monaco Asset Management first reported a position in ORIC in Q2 2022 and held it in 12 quarters. The position peaked at $3.28M in Q4 2022. 152 funds tracked by Wall St. Rank hold ORIC as of Q3 2025.

Monaco Asset Management reported no remaining Oric Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Monaco Asset Management sold 20,000 Oric Pharmaceuticals shares in Q3 2025, an estimated $203K.
Monaco Asset Management first reported a position in Oric Pharmaceuticals in Q2 2022 and held it in 12 quarters.
Monaco Asset Management's Oric Pharmaceuticals position peaked at $3.28M in Q4 2022.
152 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2025.

Based on Monaco Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.